Is anxiety best conceived as a unitary condition? The benefits of lumping compared with splitting..

Canadian Journal of Psychiatry

Volumn 59, Issue 6, 2014, Pages 291-293

  Richter, MargaretA ^a,b  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Anxiety disorders; Diagnostic and statistical manual of mental disorders fifth edition; Nosology; Psychiatric disorders

Indexed keywords

DNA;

ANXIETY; ANXIETY DISORDER; ATTENTION DEFICIT DISORDER; BIPOLAR DISORDER; COGNITIVE THERAPY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE CLASSIFICATION; DSM-5; DSM-IV-TR; EDITORIAL; FUNCTIONAL NEUROIMAGING; GENETIC RISK; GENOTYPE PHENOTYPE CORRELATION; HUMAN; MEDICAL GENETICS; MEDICAL RESEARCH; MENTAL DISEASE; NEUROBIOLOGY; OBSESSIVE COMPULSIVE DISORDER; POSTTRAUMATIC STRESS DISORDER; PSYCHIATRIC DIAGNOSIS; SCHIZOPHRENIA; TREATMENT DURATION;

ANXIETY DISORDERS; CANADA; CROSS-SECTIONAL STUDIES; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; HUMANS; MEDICALIZATION; MENTAL DISORDERS; UNITED STATES;

EID: 84903385950     PISSN: 07067437     EISSN: 14970015     Source Type: Journal    
DOI: 10.1177/070674371405900601     Document Type: Editorial

References (14)

1. American Psychiatric Association (APA). Diagnostic and statistical manual of mental disorders. 5th ed. Washington (DC): APA; 2013.
2. Kessler RC, Wang PS. The descriptive epidemiology of commonly occurring mental disorders in the United States. Annu Rev Public Health. 2008;29:115-129. (Pubitemid 351600402)
3. Insel T, Cuthbert B, Garvey M, et al. Research domain criteria (RDoC): toward a new classification framework for research on mental disorders. Am J Psychiatry. 2010;167(7):748-751.
4. McKusick VA. On lumpers and splitters, or the nosology of genetic disease. Perspect Biol Med. 1969;12(2):298-312.
5. Cross-Disorder Group of the Psychiatric Genomics Consortium. Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet. 2013;45(9):984-994.
6. Schwartz TL, Sachdeva S, Stahl SM. Glutamate neurocircuitry: theoretical underpinnings in schizophrenia. Front Pharmacol. 2012;3:195.
7. Sanacora G, Treccani G, Popoli M. Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders. Neuropharmacology. 2012;62(1):63-77.
8. Grados MA, Specht MW, Sung HM, et al. Glutamate drugs and pharmacogenetics of OCD: a pathway-based exploratory approach. Expert Opin Drug Discov. 2013;8(12):1515-1527.
9. Swanson CJ, Bures M, Johnson MP, et al. Metabotropic glutamate receptors as novel targets for anxiety and stress disorders. Nat Rev Drug Discov. 2005;4(2):131-144. (Pubitemid 40277494)
10. Riaza Bermudo-Soriano C, Perez-Rodriguez MM, Vaquero-Lorenzo C, et al. New perspectives in glutamate and anxiety. Pharmacol Biochem Behav. 2012;100(4):752-774.
11. Stein DJ, Fineberg NA, Bienvenu OJ, et al. Should OCD be classified as an anxiety disorder in DSM-V? Depress Anxiety. 2010;27:495-506.
12. Stein DJ, Craske MG, Friedman MJ, et al. Meta-structure issues for the DSM-5: how do anxiety disorders, obsessive-compulsive and related disorders, post-traumatic disorders, and dissociative disorders fit together? Curr Psychiatry Rep. 2011;13(4):248-250.
13. Peterson A, Thome J, Frewen, et al. Resting-state neuroimaging studies: a new way of identifying differences and similarities among the anxiety disorders? Can J Psychiatry. 2014;59(6):294-300.
14. Rector NA, Man V, Lerman B. The expanding cognitive-behavioural therapy treatment umbrella for the anxiety disorders: disorder-specific and transdiagnostic approaches. Can J Psychiatry. 2014;59(6):301-309.